Jiva Institue of Vedic Science & Culture – Trademark Portfolio
Entity Type: 98
Jiva Institue of Vedic Science & Culture holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include JIVA AYURVEDA.
1144, Sector – 19,
Faridabad 121002 Haryana
Showing of trademarks Trademarks
Trademark Classifications
Jiva Institue of Vedic Science & Culture's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Jiva Institue of Vedic Science & Culture have?
Jiva Institue of Vedic Science & Culture has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Jiva Institue of Vedic Science & Culture file in?
Jiva Institue of Vedic Science & Culture files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Jiva Institue of Vedic Science & Culture's most well-known trademarks?
Jiva Institue of Vedic Science & Culture's registered trademark portfolio includes well-known marks such as JIVA AYURVEDA. These are among 1 currently registered trademark in the portfolio.
What is Jiva Institue of Vedic Science & Culture's trademark registration success rate?
Jiva Institue of Vedic Science & Culture has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.